/Home/USA/Private Equity: Buyouts: High-end Capability in USA - Nationwide/Debevoise & Plimpton LLP
View profile of Debevoise & Plimpton LLP
Department profile
Debevoise & Plimpton LLP
Department profile | Debevoise & Plimpton LLP
Private Equity: Buyouts: High-end Capability

Chambers Review

Provided by Chambers

Private Equity: Buyouts: High-end Capability - USA - Nationwide

2
Band 2

What the Team is Known For

Debevoise & Plimpton LLP is experienced in a significant array of US and cross-border buyouts, often working with high-level funds and target corporations. Brings to bear an integrated global practice, able to provide support in areas such as tax, litigation and corporate governance. Demonstrates considerable strength in the healthcare sector, with notable experience handling investments into drug, device and wider consumer product manufacturers.

Notable practitioners

New York-based Kevin Schmidt is a key contact.

Work Highlights

Provided by Debevoise & Plimpton LLP

  • Debevoise & Plimpton LLP advised Clayton Dubilier & Rice and TPG Capital in their acquisition of all outstanding shares of Covetrus.

Strengths

Provided by Chambers

"Debevoise are very commercially-minded and have excellent M&A and financing capabilities."

Private Equity: Buyouts: High-end Capability respondent
USA

"They have a very good private equity offering, and have a lot of experience working with sponsors."

Private Equity: Buyouts: High-end Capability respondent
USA

"Debevoise are very efficient. They offer strong quality and have a good turnaround."

Private Equity: Buyouts: High-end Capability respondent
USA